Phase
Condition
Stimulant Use Disorder
Opioid Use Disorder
Treatment
Extended-release injectable naltrexone
Sparrow Ascent Therapy System
Lofexidine
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Participant shows signs of current opioid dependence; prescription or non-prescription
Participant COWS score is ≥ 8 or in the opinion of the investigator the participant is in mild to moderate withdrawal at the baseline assessment
Participant is between 18 and 65 years of age
Participant is English proficient
Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements
Exclusion Criteria
Participant presents current evidence of an uncontrolled and/or clinically significant medical condition or psychiatric condition
Participant has a history of epileptic seizures
Participant has a history of neurological diseases or traumatic brain injury
Participants using long-acting opioids such as methadone or buprenorphine for a period of five or more consecutive days prior to enrollment
Participant has recent suicide attempt leading to current hospital admission or continued expressed suicidal ideation
Participant has presence of devices, e.g., pacemakers, cochlear prosthesis, neurostimulators
Participant has abnormal ear anatomy or ear infection present
Participant is unwilling to transition to opioid antagonist medication following acute detox treatment
Subject has significant current suicidal ideation within 30 days prior to Screening as evidenced by answering "yes" to questions 4 or 5 on the suicidal ideation portion of the Columbia-Suicide Severity Rating Scale (C-SSRS) completed at Screening, that, in the opinion of the investigator, warrants exclusion from the trial
Women of childbearing potential, not using adequate contraception as per investigator judgment or not willing to comply with contraception for the duration of the study
Females who are pregnant or lactating
Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial
Study Design
Study Description
Connect with a study center
Hazelden Betty Ford Foundation
Rancho Mirage, California 92270
United StatesSite Not Available
Gaudenzia, Inc.
Baltimore, Maryland 21215
United StatesSite Not Available
Gaudenzia, Inc.
Crownsville, Maryland 21032
United StatesSite Not Available
Hazelden Betty Ford Foundation
Center City, Minnesota 55012
United StatesSite Not Available
Hazelden Betty Ford Foundation
Plymouth, Minnesota 55441
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.